J Korean Neurol Assoc.
2006 Oct;24(5):495-497.
Gabapentin-induced Myoclonus in a Patient with End-stage Renal Disease
- Affiliations
-
- 1Department of Neurology, Hallym University College of Medicine, Anyang, Korea. joooyon@hotmail.com
Abstract
- Myoclonus manifests in a variety of situations including epilepsy, metabolic derangements, brain lesions, and toxicity of drugs. A 57-year-old woman with end-stage renal disease was given gabapentin 900 mg/day for legs' paresthesia. Two days after taking gabapentin, multifocal myoclonus developed involving all extremities. Three days after discontinuation of gabapentin, myoclonus resolved completely. No deterioration of renal function was noted before and after the occurrence of myoclonus. Administration of gabapentin should be performed with caution in patients with impaired renal function.
Keyword
- Full Text Links
-
- Actions
-
Cited
- CITED
-
- Close
- Share
-
- Similar articles
-
- A Case of Gabapentin-induced Myoclonus in a Type 2 Diabetic Patient with End-stage Renal Disease
- Myoclonus Induced by the Use of Gabapentin
- Low-Dose Baclofen-Induced Encephalopathy in a Patient with End-Stage Renal Disease: A Case Report
- Vigabatrin-Induced Multifocal Action Myoclonus in a Patient with Partial Epilepsy
- A Case of Serotonin Syndrome Due to Amantadine and Escitalopram in End-Stage Renal Disease
